COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,580 Articles (22,415 medRxiv, 8,165 bioRxiv)

Most recent first Previous |  Page 492: Articles 4911-4920  | Next

Correlates of protection against SARS-CoV-2 Omicron variant and anti-spike antibody responses after a third/booster vaccination or breakthrough infection in the UK general population
Wei, J., Matthews, P. C., Stoesser, N., Newton, J., Diamond, I., Studley, R., Taylor, N., Bell, J., Farrar, J., Marsden, B., Kolenchery, J., Hoosdally, S., Jones, Y., Stuart, D., Crook, D., Peto, T. E., Walker, A. S., Pouwels, K., Eyre, D. W.
10.1101/2022.11.29.22282916 — Posted: 2022-11-30
SARS-CoV-2 Envelope-mediated Golgi pH dysregulation interferes with ERAAP retention in cells
Vargas-Zapata, V., Geiger, K. M., Tran, D., Ma, J., Mao, X., Puschnik, A. S., Coscoy, L.
10.1101/2022.11.29.518257 — Posted: 2022-11-30
An Optimized Circular Polymerase Extension Reaction-based Method for Functional Analysis of SARS-CoV-2
Liu, G., Gack, M.
10.1101/2022.11.26.518005 — Posted: 2022-11-30
Epidemiological impact of a large number of incorrect negative SARS-CoV-2 test results in South West England during September and October 2021
Hounsome, L., Herr, D., Bryant, R., Smith, R., Loman, L., Harris, J., Youhan, U., Dzene, E., Hadjipantelis, P., Long, H., Laurence, T., Riley, S., Cumming, F.
10.1101/2022.11.30.22282922 — Posted: 2022-11-30
Vaccine hesitancy, reactogenicity and immunogenicity of BNT162b2 and CoronaVac in pediatric patients with neuromuscular diseases
Yu, M. K. L., Chan, H. S. S., Cheng, S., Leung, D., Chan, S. M., Suen, A. K. Y., Wong, W. H. S., Peiris, M., Lau, Y. L., Rosa Duque, J. S.
10.1101/2022.11.29.22282857 — Posted: 2022-11-30
DAPTEV: Deep aptamer evolutionary modelling for COVID-19 drug design
Andress, C., Kappel, K., Cuperlovic-Culf, M., Yan, H., Li, Y.
10.1101/2022.11.30.518473 — Posted: 2022-11-30
Proteomic profiling identifies biomarkers of COVID-19 severity
Harriott, N. C., Ryan, A. L.
10.1101/2022.11.29.518411 — Posted: 2022-11-30
Non-COVID-19 mortality in France, April 2020 - June 2022: reduction compared to pre-pandemic mortality patterns, relative increase during the Omicron period, and the importance of detecting SARS-CoV-2 infections
Goldstein, E.
10.1101/2022.11.28.22282832 — Posted: 2022-11-29
Trajectories of host-response biomarkers and inflammatory subphenotypes in COVID-19 patients across the spectrum of respiratory support.
Lu, M., Drohan, C., Bain, W., Shah, F. A., Bittner, M., Evankovich, J., Prendergast, N., Hensley, M., Suber, T., Fitzpatrick, M., Ramanan, R., Murray, H., Schaefer, C., Qin, S., Wang, X., Zhang, Y., Nouraie, S. M., Gentry, H., Kessinger, C., Patel, A., Macatangay, B. J., Jacobs, J., Mellors, J., Lee, J. S., Ray, P., Ray, A., Methe, B., Morris, A., McVerry, B. J., Kitsios, G. D.
10.1101/2022.11.28.22282858 — Posted: 2022-11-29
Atomic-level characterization of the conformational transition pathways in SARS-CoV-1 and SARS-CoV-2 spike proteins
Ogden, D. S., Moradi, M.
10.1101/2022.11.29.518406 — Posted: 2022-11-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).